🇺🇸 FDA
Patent

US 9630999

Use of Salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

granted A61KA61K38/00A61K38/164

Quick answer

US patent 9630999 (Use of Salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases) held by Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China
Grant date
Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/164, A61K9/2806, A61K9/2893